Top

The journal of nutrition, health & aging

Published in:

01-06-2019 | Sarcopenia

Association between Sarcopenia and Overactive Bladder in Elderly Diabetic Patients

Authors: Satoshi Ida, R. Kaneko, H. Nagata, Y. Noguchi, Y. Araki, M. Nakai, S. Ito, K. Imataka, K. Murata

Published in: The journal of nutrition, health & aging | Issue 6/2019

Abstract

Objectives

To determine the association between sarcopenia and overactive bladder (OAB) in elderly diabetic patients using the Japanese version of SARC-F called SARC-F-J.

Design

Cross-sectional study.

Settings and participants

The study included 329 elderly diabetic patients (aged ≥65 years) who regularly visited the outpatient clinic at Community hospital in Japan.

Measurements

The condition of OAB was evaluated using the OAM symptom score, which involves a self-administered questionnaire, and sarcopenia was evaluated using the self-administered SARC-F-J questionnaire comprising five items. The odds ratio for OAB due to sarcopenia was calculated using multiple logistic regression analysis, with OAB as the dependent variable and sarcopenia as the explanatory variable.

Results

A total of 329 patients (186 males, 143 females) were included for analysis in the present study. Of these patients, 22.9% had sarcopenia and 18.7% had OAB. After adjusting the variables, the odds ratio for OAB due to sarcopenia was 4.46 (95% confidence interval [CI], 1.14–17.36, P = 0.031) and 2.09 (95% CI, 0.52–8.26, P = 0.293) for males and females, respectively.

Conclusion

This study found that sarcopenia was significantly associated with OAB in elderly diabetic male patients based on SARC-F-J. Moreover, the possibility of the development of OAB should be considered during the medical examinations of elderly diabetic male patients with sarcopenia.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010;29:4–20.

Bartoli S, Aguzzi G, Tarricone R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology 2010;75:491–500.CrossRefPubMed

Coyne KS, Sexton CC, Kopp Z, Chapple CR, Kaplan SA, Aiyer LP, Symonds T. Assessing patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract 2010;64:1260–1278.CrossRefPubMed

Zarowitz BJ, Allen C, O’Shea T, Tangalos E, Berner T, Ouslander JG. Clinical burden and nonpharmacologic management of nursing facility residents with overactive bladder and/or urinary incontinence. Consult Pharm 2015;30:533–542.CrossRefPubMed

Ganz ML, Smalarz AM, Krupski TL, Anger JT, Hu JC, Wittrup-Jensen KU, Pashos CL. Economic costs of overactive bladder in the United States. Urology 2010;75:526–532.CrossRefPubMed

Nuotio M, Tammela TL, Luukkaala T, Jylha M. Urgency and urge incontinence in an older population: ten-year changes and their association with mortality. Aging Clin Exp Res 2002;14:412–419.CrossRefPubMed

Liu RT, Chung MS, Lee WC, Chang SW, Huang ST, Yang KD, Chancellor MB, Chuang YC. Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology 2011;78:1040–1045.CrossRefPubMed

Ikeda M, Nozawa K. Prevalence of overactive bladder and its related factors in Japanese patients with diabetes mellitus. Endocr J 2015;62:847–854.CrossRefPubMed

Xu D, Cheng R, Ma A, Zhao M, Wang K. Toileting behaviors and overactive bladder in patients with type 2 diabetes: a cross-sectional study in China. BMC Urol 2017;17:42.CrossRefPubMedPubMedCentral

10.

Wen JG, Li JS, Wang ZM, Huang CX, Shang XP, Su ZQ, Lu YT, Suo ZH, Wang Y, Qin GJ, Zhang WX, Heesakkers JP. The prevalence and risk factors of OAB in middle-aged and old people in China. Neurourol Urodyn 2014;33:387–391.CrossRefPubMed

11.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423.CrossRefPubMedPubMedCentral

12.

Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010;33:1497–1499.CrossRefPubMedPubMedCentral

13.

Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013;14:531–532.CrossRefPubMed

14.

Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28–36.CrossRefPubMed

15.

Ida S, Murata K, Nakadachi D, Ishihara Y, Imataka K, Uchida A, Monguchi K, Kaneko R, Fujiwara R, Takahashi H. Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res 2016;29:935–942.CrossRefPubMedPubMedCentral

16.

Ida S, Nakai M, Ito S, Ishihara Y, Imataka K, Uchida A, Monguchi K, Kaneko R, Fujiwara R, Takahashi H, Murata K. Association Between Sarcopenia and Mild Cognitive Impairment Using the Japanese Version of the SARC-F in Elderly Patients With Diabetes. J Am Med Dir Assoc 2017;18:809.e9–809.e13.CrossRef

17.

Ida S, Murata K, Nakai M, Ito S, Malmstrom TK, Ishihara Y, Imataka K, Uchida A, Monguchi K, Kaneko R, Fujiwara R, Takahashi H. Relationship between sarcopenia and depression in older patients with diabetes: An investigation using the Japanese version of SARC-F. Geriatr Gerontol Int 2018;18:1318–1322.CrossRefPubMed

18.

Tyagi P, Tyagi V, Qu X, Lin HT, Kuo HC, Chuang YC, Chancellor M. Association of inflammaging (inflammation + aging) with higher prevalence of OAB in elderly population. Int Urol Nephrol 2014;46:871–877.CrossRefPubMed

19.

Yamaguchi O, Nomiya M, Andersson KE. Functional consequences of chronic bladder ischemia. Neurourol Urodyn 2014;33:54–58.CrossRefPubMed

20.

Azadzoi KM, Tarcan T, Kozlowski R, Krane RJ, Siroky MB. Overactivity and structural changes in the chronically ischemic bladder. J Urol 1999;162:1768–1778.CrossRefPubMed

21.

Kinugasa Y, Yamamoto K. The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction. Heart 2017;103:184–189.CrossRefPubMed

22.

Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc 2015;74:405–412.CrossRefPubMed

23.

Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology 2006;68:318–323.CrossRefPubMed

24.

Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010;25:859–866.

25.

Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, Kato T, Kojima T, Fukui M (2016) Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int 2016;36:713–720.CrossRefPubMed

26.

Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Yoshida M, Otsubo T, Gejyo F. The patient health questionnaire, Japanese version: validity according to the miniinternational neuropsychiatric interview-plus. Psychol Rep 2007;101:952–960.PubMed

27.

Hanyu H, Maezono M, Sakurai H, Kume K, Kanetaka H, Iwamoto T. Japanese version of the Test Your Memory as a screening test in a Japanese memory clinic. Psychiatry Res 2011;190:145–148.CrossRefPubMed

28.

Doi Y, Minowa M, Uchiyama M, Okawa M, Kim K, Shibui K, Kamei Y. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 2000;97:165–172.CrossRefPubMed

29.

Suskind AM, Quanstrom K, Zhao S, Bridge M, Walter LC, Neuhaus J, Finlayson E. Overactive bladder is strongly associated with frailty in older individuals. Urology 2007;106:26–31.CrossRef

30.

Bouchi R, Fukuda T, Takeuchi T, Minami I, Yoshimoto T, Ogawa Y. Sarcopenia is associated with incident albuminuria in patients with type 2 diabetes: A retrospective observational study. J Diabetes Investig 2017;8:783–787.CrossRefPubMedPubMedCentral

31.

Beshay E, Carrier S. Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 2004;64:1062–1067.CrossRefPubMed

32.

Villablanca AC, Jayachandran M, Banka C. Atherosclerosis and sex hormones: current concepts. Clin Sci (Lond) 2010;119:493–513.CrossRef

33.

Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction: current translational knowledge. J Urol 2009;182:S18–26.CrossRefPubMedPubMedCentral

34.

Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc 2011;59:1465–1470.CrossRefPubMed

35.

Singh NA, Quine S, Clemson LM, Williams EJ, Williamson DA, Stavrinos TM, Grady JN, Perry TJ, Lloyd BD, Smith EU, Singh MA. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled trial. J Am Med Dir Assoc 2012;13:24–30.CrossRefPubMed

36.

Tieland M, Dirks ML, van der Zwaluw N, Verdijk LB, van de Rest O, de Groot LC, van Loon LJ. Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 2012;13:713–719.CrossRefPubMed

37.

Burgio KL, Goode PS, Johnson TM II, Hammontree L, Ouslander JG, Markland AD, Colli J, Vaughan CP, Redden DT. Behavioral versus drug treatment for overactive bladder in men: the male overactive bladder treatment in veterans (MOTIVE) trial. J Am Geriatr Soc 2011;59:2209–2216.CrossRefPubMed

38.

Lofgren OE. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol 2007;178:1553–1553.CrossRefPubMed

Title: Association between Sarcopenia and Overactive Bladder in Elderly Diabetic Patients
Authors: Satoshi Ida
R. Kaneko
H. Nagata
Y. Noguchi
Y. Araki
M. Nakai
S. Ito
K. Imataka
K. Murata
Publication date: 01-06-2019
Publisher: Springer Paris
Keywords: Sarcopenia
Overactive Bladder
Published in: The journal of nutrition, health & aging / Issue 6/2019
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-019-1190-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association between Sarcopenia and Overactive Bladder in Elderly Diabetic Patients

Abstract

Objectives

Design

Settings and participants

Measurements

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objectives

Design

Settings and participants

Measurements

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2019

Association between Dysphagia and Frailty in Community Dwelling Older Adults

HDL Cholesterol Is Independently Associated with Cognitive Function in Males But Not in Females within a Cohort of Nonagenarians: The Mugello Study

Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People

Ionized and Total Magnesium Levels Change during Repeated Exercise in Older Adults

Twenty-Four Months’ Resistance and Endurance Training Improves Muscle Size and Physical Functions but Not Muscle Quality in Older Adults Requiring Long-Term Care

Development of a Brief Caregiver-centric Screening Tool to Identify Risk of Depression among Caregivers of Hospitalized Older Adults

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page